CORONA Remedies Limited (NSE:CORONA)
India · Delayed Price · Currency is INR 1,388.30
-70.50 (-4.83%)
At close: Jan 21, 2026
CORONA Remedies Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 1,750 | 1,494 | 905.03 | 849.29 | -4 | 699.46 |
Depreciation & Amortization | 375.51 | 368.61 | 279.84 | 199.04 | 202.82 | 157.07 |
Other Amortization | 2.99 | 2.99 | 2.94 | 1.99 | 2.02 | 1.8 |
Loss (Gain) From Sale of Assets | 10.75 | 7.05 | 12.05 | 0.2 | - | - |
Loss (Gain) From Sale of Investments | -0.5 | -0.2 | -2.56 | -2.46 | -1.01 | -7.71 |
Loss (Gain) on Equity Investments | -3.65 | -3.85 | -0.06 | -2.28 | - | - |
Provision & Write-off of Bad Debts | 1.43 | 0.53 | -1.32 | 2.21 | 0.65 | 1.16 |
Other Operating Activities | 198 | 206.1 | 278.51 | 28.16 | -20.02 | 85.1 |
Change in Accounts Receivable | -332.48 | -183.58 | -126.31 | -129.17 | 1,329 | -340.22 |
Change in Inventory | -18.67 | -333.87 | 64.71 | -314.54 | -433.47 | -76.18 |
Change in Accounts Payable | 14.4 | 294.2 | 201.16 | 98.28 | 125.56 | 238.1 |
Change in Other Net Operating Assets | -6.46 | 52.64 | -46.41 | 296.28 | -224.01 | 33.04 |
Operating Cash Flow | 1,992 | 1,905 | 1,568 | 1,027 | 977.05 | 791.62 |
Operating Cash Flow Growth | - | 21.52% | 52.64% | 5.11% | 23.42% | - |
Capital Expenditures | -833.58 | -916.48 | -2,863 | -947.58 | -340.07 | -446.47 |
Sale of Property, Plant & Equipment | 9.07 | 6.37 | 5.71 | 9.5 | - | - |
Investment in Securities | -245.97 | 27.53 | 144.61 | 375.88 | -404.07 | -586.71 |
Other Investing Activities | 44.28 | 44.18 | 46.65 | 59.75 | 86.34 | 12.01 |
Investing Cash Flow | -1,026 | -838.4 | -2,666 | -502.45 | -657.8 | -1,021 |
Short-Term Debt Issued | - | - | 288.11 | 2.64 | - | - |
Long-Term Debt Issued | - | - | 1,800 | - | - | 299.53 |
Total Debt Issued | - | - | 2,088 | 2.64 | - | 299.53 |
Short-Term Debt Repaid | - | -204.47 | - | - | -26.85 | -208.29 |
Long-Term Debt Repaid | - | -533.78 | -788.59 | -336.64 | -151.67 | -72.66 |
Total Debt Repaid | -442.95 | -738.25 | -788.59 | -336.64 | -178.52 | -280.95 |
Net Debt Issued (Repaid) | -442.95 | -738.25 | 1,300 | -334 | -178.52 | 18.58 |
Common Dividends Paid | -447.09 | -226.29 | -169.41 | -69.72 | -69.94 | - |
Other Financing Activities | -84.75 | -101.35 | -144.66 | -43.75 | -50.14 | -17.65 |
Financing Cash Flow | -974.79 | -1,066 | 985.45 | -447.47 | -298.6 | 0.93 |
Foreign Exchange Rate Adjustments | 0.1 | - | 0.02 | -0.38 | -0.3 | 0.01 |
Net Cash Flow | -9.23 | 0.67 | -113.38 | 76.7 | 20.35 | -228.6 |
Free Cash Flow | 1,158 | 988.48 | -1,296 | 79.42 | 636.98 | 345.16 |
Free Cash Flow Growth | - | - | - | -87.53% | 84.55% | - |
Free Cash Flow Margin | 8.91% | 8.26% | -12.77% | 0.90% | 10.32% | 5.99% |
Free Cash Flow Per Share | 18.94 | 16.16 | -21.19 | 1.36 | 12.48 | 5.64 |
Cash Interest Paid | 84.75 | 101.35 | 144.66 | 43.75 | 50.14 | 17.65 |
Cash Income Tax Paid | 502.36 | 432.76 | 179.05 | 258.22 | 14.99 | 276.14 |
Levered Free Cash Flow | - | 522.69 | -1,796 | -24.62 | -221.01 | - |
Unlevered Free Cash Flow | - | 587.43 | -1,709 | -0.07 | -192.59 | - |
Change in Working Capital | -343.21 | -170.61 | 93.15 | -49.15 | 796.59 | -145.25 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.